India's Sagility rises on higher quarterly profit

By Reuters News

** Sagility SAGL.NS shares rise as much as 3.6%; last up 1.1% at 45.9 rupees

** Health tech provider's Q2 consol net profit rises 13.3% to 2.84 billion Indian rupees; consol rev from ops up 22.5% to 20.32 billion rupees

** Jefferies ("Buy"; PT: 59 rupees) says co's earnings beats estimates

** Brokerage notes revenue growth was driven by growth in co's payer segment; says co's client metrics look encouraging

** Expects co to deliver ~12.5% CAGR for revenue over FY26-29

** Nomura ("Buy"; hikes PT to 56 rupees from 53 rupees) says co's strong domain expertise and client relationships position it well for sustained growth in the medium term

** Stock rated as "strong buy" on average by 9 analysts; median PT at 54.5 rupees -- LSEG-compiled data

** YTD, stock down 11.4%

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.